ONLINE via Zoom (Zoom link will be provided)
Indra Rudiansyah is a DPhil student at the Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford.
After finishing his undergraduate (2013) studies from the Bandung Institute of Technology in Indonesia (ITB), Indra completed his master’s degree in biotechnology through a fast-track program at the same University in 2014. He then joined Bio Farma, an Indonesian state-owned vaccine enterprise in Indonesia, for 4 years as a researcher before starting his DPhil.
During his professional career, he has been involved in the process development of rotavirus and novel oral polio vaccine in collaboration with BMGF and PATH. Now his research focuses on the development of the pre-erythrocytic malaria vaccine, using chimpanzee adenovirus as a viral vector. During COVID19 Pandemic, Indra joined the clinical trial team to evaluate the ChAdOX1-nCOV19, a candidate vaccine for COVID19 that has been developed at the University of Oxford.
Indra will be talking about his personal experiences as a student in Indonesia and now as a DPhil (PhD) student at Oxford University.